Nicolas Lazaretti

711 total citations
15 papers, 70 citations indexed

About

Nicolas Lazaretti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Nicolas Lazaretti has authored 15 papers receiving a total of 70 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Nicolas Lazaretti's work include Radiopharmaceutical Chemistry and Applications (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Cancer Treatment and Pharmacology (2 papers). Nicolas Lazaretti is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Cancer Treatment and Pharmacology (2 papers). Nicolas Lazaretti collaborates with scholars based in Brazil, United States and Colombia. Nicolas Lazaretti's co-authors include Luís Alberto Schlittler, J. G. M. Segalla, Auro del Giglio, Nora Manoukian Forones, Carlos José Coelho de Andrade, Gustavo Girotto, Fauze Maluf‐Filho, José Luiz Pedrini, Gilberto de Castro and Sérgio Jobim Azevedo and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Nicolas Lazaretti

13 papers receiving 70 citations

Peers

Nicolas Lazaretti

PRM

SURGE

ONCOL

EPIDE

Gabriel Raab United States

Coline HM van Moorsel Netherlands

Luís Alberto Schlittler Brazil

Hiroyuki Nakajima Japan

Jason Wong Australia

Inmaculada Lasa Spain

Maho Ogawa Japan

Jyoti Sharma India

Raquel Ortigão Portugal

Aurélie Parzy France

Gabriel Raab United States

Nicolas Lazaretti

22 ×0.6

PRM

28 ×0.8

SURGE

44 ×1.8

ONCOL

18 ×1.8

14 ×1.4

EPIDE

Citations per year, relative to Nicolas Lazaretti Nicolas Lazaretti (= 1×) peers Gabriel Raab

Countries citing papers authored by Nicolas Lazaretti

Since Specialization

Citations

This map shows the geographic impact of Nicolas Lazaretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Lazaretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Lazaretti more than expected).

Fields of papers citing papers by Nicolas Lazaretti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Lazaretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Lazaretti. The network helps show where Nicolas Lazaretti may publish in the future.

Co-authorship network of co-authors of Nicolas Lazaretti

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Lazaretti. A scholar is included among the top collaborators of Nicolas Lazaretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Lazaretti. Nicolas Lazaretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Fein, Luis, Nicolas Lazaretti, John R. Benfield, et al.. (2023). Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate. Clinical Drug Investigation. 43(9). 699–706. 3 indexed citations

Shore, Neal D., Karim Fizazi, Teuvo L.J. Tammela, et al.. (2023). Effect of crossover from placebo to darolutamide on overall survival in men with non-metastatic prostate cancer: sensitivity analyses from the randomised phase 3 ARAMIS study. European Journal of Cancer. 195. 113342–113342.

Shore, Neal D., Karim Fizazi, Teuvo L.J. Tammela, et al.. (2021). Analysis of the effect of crossover from placebo (PBO) to darolutamide (DARO) on overall survival (OS) benefit in the ARAMIS Trial.. Journal of Clinical Oncology. 39(6_suppl). 240–240. 1 indexed citations

Rosa, Daniela Dornelles, José Bines, Gustavo Werutsky, et al.. (2021). Sociodemographic and clinicopathologic features of elderly breast cancer patients in Brazil: A sub-analysis of AMAZONA III study (GBCAM 0115).. Journal of Clinical Oncology. 39(15_suppl). e12603–e12603. 2 indexed citations

Castro, Gilberto de, J. G. M. Segalla, Sérgio Jobim Azevedo, et al.. (2017). A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial. European Journal of Cancer. 88. 21–30. 42 indexed citations

Lazaretti, Nicolas, et al.. (2017). A clinical-pathological correlation in the diagnosis of breast sarcoma. 27(2). 144–147. 1 indexed citations

Marshall, John L., Dale E. Shuster, Terri Goldberg, et al.. (2014). A randomized, open-label phase II study of efatutazone in combination with FOLFIRI as second-line therapy for metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 32(3_suppl). 535–535. 4 indexed citations

Lazaretti, Nicolas, et al.. (2014). Fractura Patológica por Osteorradionecrosis de Mandíbula: Relato de Caso. International journal of odontostomatology. 8(1). 113–118.

Castro, Gilberto de, J. G. M. Segalla, Sérgio Jobim Azevedo, et al.. (2014). Molecular Marker Analyses of Egfr and Kras from the Randomized Phase Ii Study of Nimotuzumab in Locally Advanced Esophageal Cancer (Nice Trial). Annals of Oncology. 25. iv218–iv218. 1 indexed citations

10.

Schlittler, Luís Alberto, et al.. (2011). Carcinoma de Pequenas Células do Esófago: Apresentação de dois Casos. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 18(5). 243–246. 1 indexed citations

11.

Schlittler, Luís Alberto, et al.. (2011). Marantic endocarditis and adenocarcinoma of unknown primary site.. PubMed. 96(4). e73–5. 8 indexed citations

12.

Lazaretti, Nicolas, et al.. (2010). Tumor de células gigantes de fémur distal com metástases pulmonares. Revista Portuguesa de Pneumologia. 16(2). 331–337. 1 indexed citations

13.

Lazaretti, Nicolas, et al.. (2010). Tumor de células gigantes de fémur distal com metástases pulmonares. Revista Portuguesa de Pneumologia. 16(2). 331–337. 1 indexed citations

14.

Schlittler, Luís Alberto, et al.. (2009). True adrenal cyst mimicking renal cancer in a young woman: a case report. Cases Journal. 2(1). 7351–7351. 4 indexed citations

15.

Lazaretti, Nicolas, et al.. (2009). Mortality rate with irinotecan/cisplatin plus concomitant radiation therapy in patients with locally advanced esophageal squamous cell carcinoma. Journal of Clinical Oncology. 27(15_suppl). e15560–e15560. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact